BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 25108385)

  • 21. Comparison of
    Wang HH; He Y; Wang HX; Liao CL; Peng Y; Tao LJ; Zhang W; Yang HX
    World J Gastroenterol; 2018 Feb; 24(8):941-948. PubMed ID: 29491687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
    Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
    Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study.
    Kim JH; Cheon JH; Hong SS; Eun CS; Byeon JS; Hong SY; Kim BY; Kwon SH; Kim SW; Han DS; Yang SK; Kim WH
    J Clin Gastroenterol; 2010; 44(10):e242-8. PubMed ID: 20308917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of thiopurine S-methyltransferase gene polymorphisms in patients with inflammatory bowel disease from the island of Crete, Greece.
    Coucoutsi C; Emmanouil G; Goulielmos G; Sfakianaki O; Koutroubakis IE; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1284-1289. PubMed ID: 28857898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nudix Hydroxylase 15 Mutations Strongly Predict Thiopurine-Induced Leukopenia Across Different Asian Ethnicities: Implications for Screening in a Diverse Population.
    Khoo XH; Wong SY; Ibrahim NRW; Ng RT; Chew KS; Lee WS; Wong ZQ; Raja Ali RA; Shahrani S; Leow AH; Hilmi IN
    Front Med (Lausanne); 2022; 9():880937. PubMed ID: 35991642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of various genetic polymorphisms on thiopurine treatment-associated outcomes for Korean patients with Crohn's disease.
    Choi R; Lee MN; Kim K; Baek SY; Kim TJ; Hong SN; Kim YH; Lee SY
    Br J Clin Pharmacol; 2020 Nov; 86(11):2302-2313. PubMed ID: 32372428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A coding variant in
    Kim HS; Cheon JH; Jung ES; Park J; Aum S; Park SJ; Eun S; Lee J; Rüther U; Yeo GSH; Ma M; Park KS; Naito T; Kakuta Y; Lee JH; Kim WH; Lee MG
    Gut; 2017 Nov; 66(11):1926-1935. PubMed ID: 27558924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preemptive NUDT15 genotyping: redefining the management of patients with thiopurine-induced toxicity.
    Shah SAV; Paradkar MU; Desai DC; Ashavaid TF
    Drug Metab Pers Ther; 2018 Mar; 33(1):57-60. PubMed ID: 29470173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NUDT15 codon 139 is the best pharmacogenetic marker for predicting thiopurine-induced severe adverse events in Japanese patients with inflammatory bowel disease: a multicenter study.
    Kakuta Y; Kawai Y; Okamoto D; Takagawa T; Ikeya K; Sakuraba H; Nishida A; Nakagawa S; Miura M; Toyonaga T; Onodera K; Shinozaki M; Ishiguro Y; Mizuno S; Takahara M; Yanai S; Hokari R; Nakagawa T; Araki H; Motoya S; Naito T; Moroi R; Shiga H; Endo K; Kobayashi T; Naganuma M; Hiraoka S; Matsumoto T; Nakamura S; Nakase H; Hisamatsu T; Sasaki M; Hanai H; Andoh A; Nagasaki M; Kinouchi Y; Shimosegawa T; Masamune A; Suzuki Y;
    J Gastroenterol; 2018 Sep; 53(9):1065-1078. PubMed ID: 29923122
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Yang J; Wang P; Qin Z; Jia M; Zhang C; Tian X; Zheng Y; Zhang A; Zhang X; Liu S
    Genet Test Mol Biomarkers; 2019 Oct; 23(10):751-757. PubMed ID: 31556692
    [No Abstract]   [Full Text] [Related]  

  • 31. Association of NUDT15 c.415C>T allele and thiopurine-induced leukocytopenia in Asians: a systematic review and meta-analysis.
    Zhang AL; Yang J; Wang H; Lu JL; Tang S; Zhang XJ
    Ir J Med Sci; 2018 Feb; 187(1):145-153. PubMed ID: 28470355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early proactive monitoring of DNA-thioguanine in patients with Crohn's disease predicts thiopurine-induced late leucopenia in NUDT15/TPMT normal metabolizers.
    Yang T; Chao K; Zhu X; Wang XD; Chan S; Guan YP; Mao J; Li P; Guan SX; Xie W; Gao X; Huang M
    World J Gastroenterol; 2024 Mar; 30(12):1751-1763. PubMed ID: 38617736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe thiopurine-induced leukocytopenia and hair loss in Japanese patients with defective NUDT15 variant: Retrospective case-control study.
    Kishibe M; Nozaki H; Fujii M; Iinuma S; Ohtsubo S; Igawa S; Kanno K; Honma M; Kishibe K; Okamoto K; Ishida-Yamamoto A
    J Dermatol; 2018 Oct; 45(10):1160-1165. PubMed ID: 30101994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.
    Zelinkova Z; Derijks LJ; Stokkers PC; Vogels EW; van Kampen AH; Curvers WL; Cohn D; van Deventer SJ; Hommes DW
    Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NUDT15 C415T variant compared with TPMT genotyping in predicting azathioprine-induced leucopenia: prospective analysis of 1014 inflammatory bowel disease patients in India.
    Banerjee R; Ravikanth VV; Pal P; Bale G; Avanthi US; Goren I; Girish BG; Mitnala S; Reddy DN
    Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1683-1694. PubMed ID: 33111378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus.
    Chen D; Lian F; Yuan S; Wang Y; Zhan Z; Ye Y; Qiu Q; Xu H; Liang L; Yang X
    Clin Rheumatol; 2014 Apr; 33(4):499-503. PubMed ID: 24322830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of NUDT15 genetics on severe thiopurine-related hematotoxicity in patients with European ancestry.
    Schaeffeler E; Jaeger SU; Klumpp V; Yang JJ; Igel S; Hinze L; Stanulla M; Schwab M
    Genet Med; 2019 Sep; 21(9):2145-2150. PubMed ID: 30728528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of NUDT15 Genetic Variants and Incidence of Thiopurine-induced Leukopenia in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Yu N; Sriranganathan D; Walker GJ; Sazonovs A; Wilding H; Roberts C; Kennedy NA; Ahmad T; Boyapati RK; Ding NS; Segal JP
    J Crohns Colitis; 2023 Dec; 17(12):1920-1930. PubMed ID: 37346013
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypoxanthine guanine phosphoribosyltransferase activity is related to 6-thioguanine nucleotide concentrations and thiopurine-induced leukopenia in the treatment of inflammatory bowel disease.
    Ding L; Zhang FB; Liu H; Gao X; Bi HC; Wang XD; Chen BL; Zhang Y; Zhao LZ; Zhong GP; Hu PJ; Chen MH; Huang M
    Inflamm Bowel Dis; 2012 Jan; 18(1):63-73. PubMed ID: 21381155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease.
    Asada A; Nishida A; Shioya M; Imaeda H; Inatomi O; Bamba S; Kito K; Sugimoto M; Andoh A
    J Gastroenterol; 2016 Jan; 51(1):22-9. PubMed ID: 26590936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.